SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ralf Kubitz, Carola Dröge, Stefanie Kluge, Claudia Stross, Nathalie Walter, Verena Keitel, Dieter Häussinger, Jan Stindt, Autoimmune BSEP Disease: Disease Recurrence After Liver Transplantation for Progressive Familial Intrahepatic Cholestasis, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  2. 2
    C. Brauner, T.O. Lankisch, P. Fytili, J. Jaroszewicz, F. Lehner, H. Barg-Hock, J. Klempnauer, E. Jaeckel, M.P. Manns, H. Wedemeyer, A.A. Negm, Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease, Transplant Infectious Disease, 2014, 16, 6
  3. 3
    Zoe Mariño, Laura Mensa, Gonzalo Crespo, Rosa Miquel, Miquel Bruguera, Sofía Pérez-del-Pulgar, Jaume Bosch, Xavier Forns, Miquel Navasa, Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation, Journal of Hepatology, 2014, 61, 2, 270

    CrossRef

  4. 4
    Taizo Hibi, Seigo Nishida, Junichiro Sageshima, David M. Levi, Phillip Ruiz, David Roth, Paul Martin, Koji Okabayashi, George W. Burke, Gaetano Ciancio, Andreas G. Tzakis, Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C, Transplant International, 2014, 27, 6
  5. 5
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Norihiro Kokudo, Susumu Eguchi, Toshiyoshi Fujiwara, Hideki Ohdan, Hiroaki Nagano, Akinobu Taketomi, Yuko Kitagawa, Mitsuo Shimada, Yonson Ku, Katsuhiko Yanaga, Ken Shirabe, Toru Ikegami, Masashi Mizokami, Masahiro Takeuchi, Yoshihiko Maehara, Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey, Transplant International, 2014, 27, 8
  6. 6
    Toru Ikegami, Huanlin Wang, Tomoharu Yoshizumi, Takeo Toshima, Shinichi Aishima, Takasuke Fukuhara, Norihiro Furusyo, Kazuhiro Kotoh, Shinji Shimoda, Ken Shirabe, Yoshihiko Maehara, Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C, Hepatology International, 2014, 8, 2, 285

    CrossRef

  7. You have free access to this content7
    JP Norvell, Josh Levitsky, Donor and recipient effects on graft and patient survival, Clinical Liver Disease, 2013, 2, 4
  8. 8
    Marina Berenguer, Geoffrey McCaughan, Hepatitis C Virus–Associated Cholestatic Hepatitis: We Cannot Seem to Agree on Diagnostic Criteria, Liver Transplantation, 2013, 19, 2
  9. 9
    Christoph Jüngst, Thomas Berg, Jun Cheng, Richard M. Green, Jidong Jia, Andrew L. Mason, Frank Lammert, Intrahepatic cholestasis in common chronic liver diseases, European Journal of Clinical Investigation, 2013, 43, 10
  10. 10
    Andrew L. Mason, Aldo J. Montano-Loza, Systematic investigation of elevated cholestatic enzymes during the third posttransplant month, Liver Transplantation, 2013, 19, S2